ClosedPublished 23 Feb 2023

Dragon Scientific, LLC /
Razor Genomics, Inc.

Dragon Scientific buys majority stake in Razor Genomics

Terms
Not stated
Stage
Closed
Buy side: Dragon Scientific, LLC
Buy sideDragon Scientific, LLC
Target: Razor Genomics, Inc.
TargetRazor Genomics, Inc.
Source · 23 Feb 2023
Buy side: Dragon Scientific, LLC
Buy sideDragon Scientific, LLC
Target: Razor Genomics, Inc.
TargetRazor Genomics, Inc.
01 / BuyerDragon Scientific, LLC
02 / TargetRazor Genomics, Inc.
01

What happened

Dragon Scientific, LLC completed its purchase of 70% of Razor Genomics, Inc. Oncocyte Corporation continues to own approximately 30% of Razor.

No monetary consideration was received for the sale. The transaction allows Oncocyte to eliminate development and commercialization costs related to DetermaRx.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Dragon Scientific buys majority stake in Razor Genomics

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.